EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies

Adnan Cetin iD, Ercan Oguz, Ewa Wolińska, Przemysław Rozbicki, Danuta Branowska, Fikret Türkan

Journal of Biochemical and Molecular Toxicology · 2025-11 · 39 (11)

DOI: 10.1002/jbt.70591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 06.11.2025. Verfasst von Adnan Cetin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Education, Van Yuzuncu Yil University, Van, Türkiye. Hauptthemen laut MEDLINE: Triazines, Molecular Docking Simulation, Antineoplastic Agents, Drug Design. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

1,2,4‐Triazines exhibit various pharmacological properties due to their strong biological activities, such as anticancer, anti‐inflammatory, antimicrobial, antiviral, and antioxidant, and also occupy an important place in the pharmaceutical field. The tested compounds were synthesized and characterized. 1,2,4‐Triazines were evaluated for their inhibitory and cytotoxicity effects on acetylcholinesterase (AChE), glutathione S‐transferase (GST), human liver cancer cell line (HepG2), and human colorectal adenocarcinoma cell line (HT‐29). 1,2,4‐Triazines ( 3a ‐ c , 5 , 6 , 10 ) were found to inhibit these enzymes with IC 50 values ranging from 1.41 to 4.28 μM for AChE and from 1.58 to 4.13 μM for GST. 1,2,4‐Triazine compounds were tested in range of 12.5−100 µM concentrations against HepG2 and HT‐29 cell lines. Among the 1,2,4‐triazines tested, 10 was the most effective substance on HepG2 cells, especially at high doses, while 3b was effective on HT‐29. Furthermore, molecular docking results indicated that the 1,2,4‐triazines showed strong binding and stability at the active site of enzymes and selected proteins. 1,2,4‐Triazines may serve as promising precursors for the design of potent enzyme inhibitors and anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazinesMolecular Docking SimulationAntineoplastic AgentsDrug DesignGlutathione TransferaseCholinesterase InhibitorsHumansHep G2 CellsHT29 CellsAcetylcholinesterase

Stichwörter der Autor:innen

anticancerdrug discoveryenzyme inhibitionspectroscopytriazine

Substanzen

TriazinesAntineoplastic AgentsAcetylcholinesterase1,2,4-triazineGlutathione TransferaseCholinesterase Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Education, Van Yuzuncu Yil University, Van, Türkiye.
  • Department of Medical Services and Techniques, Health Services Vocational School, Igdır University, Igdır, Türkiye.
  • Institute of Chemical Sciences, University of Siedlce, Siedlce, Poland.
  • Department of Basic Sciences, Faculty of Dentistry, Igdır University, Igdır, Türkiye.
  • Department of Basic Medical Science, Medical of Faculty, Nakhichevan State University, Nakhichevan, Azerbaijan.

ORCID-Profile: Adnan Cetin

Zitieren

APA

Cetin, A., Oguz, E., Wolińska, E., Rozbicki, P., Branowska, D., & Türkan, F. (2025). Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology, 39(11). https://doi.org/10.1002/jbt.70591

Vancouver

Cetin A, Oguz E, Wolińska E, Rozbicki P, Branowska D, Türkan F. Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology. 2025;39(11). doi:10.1002/jbt.70591

BibTeX
@article{Cetin2025,
  author = {Cetin, Adnan and Oguz, Ercan and Wolińska, Ewa and Rozbicki, Przemysław and Branowska, Danuta and Türkan, Fikret},
  title = {Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {11},
  doi = {10.1002/jbt.70591}
}
Kostenlos starten →